Misako Nagasaka, MD, on Sintilimab Plus Chemotherapy for Advanced Nonsquamous Lung Cancer

Posted: Wednesday, September 2, 2020

Misako Nagasaka, MD, of the Barbara Ann Karmanos Cancer Institute, presents interim analysis data from ORIENT-11, and talks about how to give sintilimab safely, and manage and minimize adverse events.